by investoropportunity | Mar 15, 2023 | Company Research, Health, Home Page Articles of Insight, Technology, Uncategorized
PharmAla is the first for-profit company to synthesize clinical-grade (GMP) MDMA and make it available for sale to both researchers and qualified patients. PharmAla will increasingly develop a target on its back for acquisition and we expect a rise in marketcap via...
by investoropportunity | Feb 1, 2023 | Technology
What exactly is generative AI and how does it work? This infographic, created using generative AI tools such as Midjourney and ChatGPT, explains. Click image to enlarge and expand on full content in another window [external URL link]…. ## Notice: Content above...
by investoropportunity | Jan 31, 2023 | Technology
This infographic highlights eleven exciting areas within the world of technology worth keeping an eye on in 2023. Click image to enlarge in a new window. ## Notice: Content above may contain forward-looking statements regarding future events that involve risk and...
by investoropportunity | Jan 21, 2023 | Health, Home Page Articles of Insight, Technology
Editas Medicine currently trades at an enterprise value of just $561 million, but its IP portfolio alone is worth billions. This stock traded at over $80/share 2 years ago and is now under $9/share, however the reasons for buying then are just as strong now. It’s...
by investoropportunity | Nov 28, 2022 | Blockchain
– TIMESTAMPS -0:00 Intro1:54 Tracking Down SBF 5:14 FTX Hacker Dumps8:52 Genesis Global In Trouble 12:09 Binance Bailouts 15:18 Oil Shortages Incoming18:13 Ben Cowen’s Analysis23:48 Outro ## Notice: Content above may contain forward-looking statements regarding...
Recent Comments